Ability Pharma

AbilityPharma is a clinical-stage biopharmaceutical company focused on developing first-in-class, fully differentiated oral targeted anticancer compounds that selectively induce autophagy-mediated cytotoxicity in cancer cells. The company is committed to shaping the future of oncology by developing innovative therapies that induce autophagy to address unmet medical needs.